INJ declines with recent bounce from MA-20 facing MA-50 resistance: weekly forecast
Injective (INJ) is currently trading at $5.44, positioned above its MA-20 ($3.73) but below the MA-50 ($7.40) and MA-200 ($13.06) on the weekly timeframe. Over the last seven days, INJ declined $1.12 (17.36%), placing it in the lower part of its recent weekly range and highlighting notable pressure below key longer-term moving averages.
Highlights
- INJ remains under persistent selling pressure, posting a 17.36% weekly drop and trading near the bottom of its recent range.
- Momentum signals are mixed but short-term exhaustion is evident, with oscillators confirming both overbought and sustained bearish conditions.
- The price is expected to fluctuate between $4.90 support and $6.50 resistance in the coming week, with a 50/50 directional outlook.
Record user growth supports sentiment as key support zone holds
Injective is seeing record network growth, reporting a notable increase in user activity with 91,500 users. This expansion is occurring as the token holds a crucial support area near $5, which has historically provided a foundation for past rallies. No additional corporate or regulatory actions have been reported for Injective during this period.
Bullish buyers face resistance as mixed indicators flag overbought risks
Technically, the price sits above the MA-20 but remains under the MA-50 and MA-200 on the weekly chart, making the MA-50 the primary resistance area. Key support is established near $4.90, while immediate resistance lies around $6.50; volatility for the week stands at 53.56%. Weekly indicators offer mixed signals: the ADX favors buyers, bullish momentum is present on the Awesome Oscillator and Bull/Bear Power, but the MACD and Stochastic RSI indicate strong selling momentum, the RSI is neutral-bullish, and the CCI points to overbought territory, signaling exhaustion amid declining price action.
Sideways bias expected as consolidation follows recent price swings
For the next 7 days, INJ is expected to trade within a range of $4.90 to $6.50 as the market consolidates following sharp movements. There is an equal probability of upward or downward price action, with two out of four key indicators supporting a buy or strong buy outlook based on the weekly data. The baseline scenario is a sideways move within the $4.90 to $6.50 corridor, but a bullish breakout could see a push toward the $7.00 area if momentum builds, while sustained weakness could trigger a further decline below $4.90 if recent lows are breached.
Earlier, analysts noted that Injective was experiencing consolidation as network growth accelerated and investor interest expanded, setting the stage for a potential breakout. With technical signals now mixed amid persistent downside pressure and broad weekly volatility, traders should closely monitor the $4.90 support area as a pivotal level for near-term direction.
Latest Injective News
- Forex
- Crypto